ATE175357T1 - Empfängnisverhütender impfstoff - Google Patents

Empfängnisverhütender impfstoff

Info

Publication number
ATE175357T1
ATE175357T1 AT93915326T AT93915326T ATE175357T1 AT E175357 T1 ATE175357 T1 AT E175357T1 AT 93915326 T AT93915326 T AT 93915326T AT 93915326 T AT93915326 T AT 93915326T AT E175357 T1 ATE175357 T1 AT E175357T1
Authority
AT
Austria
Prior art keywords
methods
sperm
contractive
vaccine
sperm surface
Prior art date
Application number
AT93915326T
Other languages
English (en)
Inventor
Paul Primakoff
Diana G Myles
Original Assignee
Univ Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Connecticut filed Critical Univ Connecticut
Application granted granted Critical
Publication of ATE175357T1 publication Critical patent/ATE175357T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93915326T 1992-06-12 1993-06-10 Empfängnisverhütender impfstoff ATE175357T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89788392A 1992-06-12 1992-06-12

Publications (1)

Publication Number Publication Date
ATE175357T1 true ATE175357T1 (de) 1999-01-15

Family

ID=25408584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915326T ATE175357T1 (de) 1992-06-12 1993-06-10 Empfängnisverhütender impfstoff

Country Status (8)

Country Link
EP (1) EP0646015B1 (de)
JP (1) JPH08503601A (de)
KR (1) KR950701821A (de)
AT (1) ATE175357T1 (de)
AU (1) AU4534893A (de)
CA (1) CA2137077A1 (de)
DE (1) DE69322960T2 (de)
WO (1) WO1993025233A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693496A (en) * 1994-06-20 1997-12-02 Merck & Co., Inc. DNA encoding the mouse and human PH30 beta chain protein
AU3362895A (en) * 1994-08-11 1996-03-07 Duke University Use of zrk peptide sequences in contraception
EP2494985A1 (de) * 2008-04-07 2012-09-05 Auburn University Zona Pellucida-Bindungspeptide, Expressionsvektoren, Zusammensetzungen und Verfahren zur speziesspezifischen Immunokontrazeption bei Tieren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721348A (en) * 1990-12-14 1998-02-24 University Of Connecticut DNA encoding PH-20 proteins
CA2120601A1 (en) * 1991-10-04 1993-04-15 Lee M. Silver Sperm surface protein

Also Published As

Publication number Publication date
JPH08503601A (ja) 1996-04-23
WO1993025233A1 (en) 1993-12-23
KR950701821A (ko) 1995-05-17
AU4534893A (en) 1994-01-04
EP0646015B1 (de) 1999-01-07
DE69322960D1 (de) 1999-02-18
CA2137077A1 (en) 1993-12-23
DE69322960T2 (de) 1999-08-12
EP0646015A1 (de) 1995-04-05

Similar Documents

Publication Publication Date Title
CO4850562A1 (es) Proceso para producir una preparacion concentrada de anticuerpos
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
EP0658120A4 (de) Konjugate von schwach immunogenen antiogenen und synthetische peptidträger und impfstoffe diese enthaltend.
DK0618813T3 (da) Antigen for M-hybridprotein og bærer for gruppe A streptococcal vaccine
DK0561907T3 (da) Proteiner med ændrede epitoper og fremgangsmåder til fremstilling deraf
ATE277633T1 (de) Präparate und verfahren zum auslösen von ctl- immunität
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE69418699D1 (de) Induktion der antworten zytotoxischer t-lymphozyten
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
GB2255093A (en) Hiv-1 core protein fragments
EA199900067A1 (ru) Очищенный поверхностный антиген сперматозоидов, моноклональное антитело для него и их применения
Jemmerson et al. Mapping antigenic sites on proteins: Implications for the design of synthetic vaccines.
DE69029134D1 (de) Monoklonale antikörper zur induzierung von toleranz
EP2057999A3 (de) Verwendung von immunokonjugaten zur erhöhung der effektivität von mehrstufigen kaskaden-impfstoffen
EP0252064A3 (en) Preparations active against pseudomonas aeruginosa infections, and process for their preparation
PT88157A (pt) Antigenes d'excretion-secretion specifiques de toxoplasma gondii leurs produits d'expression leurs procedes d'obtention et leurs applications diagnostiques et prophylactiques
ES2060695T3 (es) Concentrados terapeuticos de igm.
DE3585370D1 (de) Kreuzreaktive und schuetzende epitope von circumsporozoit-proteinen.
ATE175357T1 (de) Empfängnisverhütender impfstoff
Larsson et al. Immunization with Nanogram Quantities of Nitrocellulose‐Bound Antigen, Electroblotted from Sodium Dodecyl Sulphate–Polyacrylamide Gels
NO883501L (no) Slekt-spesifikt listeria-antigen identifisert med monoklonale antistoffer.
EP0320866A3 (de) Schützendes immundominantes Epitop in der S1-Untereinheit von Pertussistoxin
FI854839L (fi) Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid.
NZ532271A (en) Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
DK0542895T3 (da) Krydsreaktiv influenza A immunisering

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties